When Soroosh Shambayati left his organic-chemistry lab, he didn't leave chemical synthesis behind. As a chemist PhD turned investment banker, he started working in the derivatives market in the 1990s. The transactions involved arranging a complex series of trades in a precise order, and it reminded him of synthesizing an organic compound, reaction by reaction. As a graduate student, Shambayati had excelled at synthesis, just as he did at everything he turned his hand to. He was "other-worldly brilliant", says his former adviser Stuart Schreiber. He juggled three distinct projects during his PhD, one in organic synthesis, one in theoretical physical chemistry and a third in biochemistry and immunology. He was also calm, thoughtful and well read: his bookshelf spans science philosophy, evolutionary biology and physics. Schreiber, a biochemist at the Broad Institute in Cambridge, Massachusetts, knew that if Shambayati wanted to become an academic scientist, he was sure to succeed. "It was very clear to me that he was going to become a star," he says. But Shambayati chose the financial world - and excelled there instead: he is now chief executive at Guggenheim Investment Advisors (Suisse) in Geneva, Switzerland, a firm that manages billions of dollars for wealthy families and foundations.
展开▼
